Bionano Genomics is a life sciences company in the genome analysis space. Bionano develops and markets the Saphyr system, a platform for genome-wide detection of all structural variant types in hematological malignancies enabling researchers to accelerate the search for new cancer diagnostics and therapeutic targets. Learn more: www.BionanoGenomics.com.